Premium
Prevalence and risk factors for vitamin D deficiency in long‐term childhood cancer survivors
Author(s) -
Bhandari Rusha,
Teh Jennifer Berano,
Herrera Claudia,
Echevarria Meagan,
Lindenfeld Lanie,
Wong F. Lennie,
Wilson Karla,
Armenian Saro H.
Publication year - 2021
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.29048
Subject(s) - medicine , vitamin d and neurology , overweight , underweight , vitamin d deficiency , population , odds ratio , univariate analysis , pediatrics , dual energy x ray absorptiometry , body mass index , bone mineral , demography , osteoporosis , environmental health , multivariate analysis , sociology
Background Childhood cancer survivors (CCS) have increased risk of developing chronic health conditions, including musculoskeletal disorders. Little is known regarding vitamin D deficiency (VDD, <20 ng/ml) and its association with bone mineral density (BMD) in long‐term CCS. We evaluated the prevalence and risk factors for VDD in a large, diverse population of long‐term CCS, and examined the association between VDD and BMD in patients who underwent guideline‐recommended dual‐energy X‐ray absorptiometry (DXA) screening. Methods This cross‐sectional study included 446 consecutive CCS seen from March 2018 to September 2020. Univariate analyses examined associations between CCS demographics, socioeconomic status, and treatment exposures and VDD. Multivariable logistic regressions identified factors associated with odds of VDD and reduced BMD. Results Median age at evaluation was 27.5 years (range 7–67 years); median time from completing therapy was 14.2 years (range 2–65 years). Fifty percent were female, and 45% were Hispanic. Twenty‐four percent had VDD. In multivariable analysis, overweight and obese BMI were associated with VDD (overweight: OR 1.78, 95% CI 1.03–3.07, p = 0.04; obese: OR 2.40, 95% CI 1.39–4.13, p < 0.01; reference: normal/underweight), as was Hispanic or black race/ethnicity (OR 2.40, 95% CI 1.41–4.09, p < 0.01; reference: non‐Hispanic white). In the 118 CCS with DXA results, VDD was independently associated with reduced BMD (OR 3.58, 95%CI 1.33–9.59, p = 0.01). Conclusions CCS have a high prevalence of VDD. High BMI and Hispanic or black race/ethnicity were associated with VDD. Survivors with VDD had a greater than threefold risk of reduced BMD. Risk‐based screening may facilitate timely interventions to mitigate VDD and improve BMD in CCS.